BriaCell Therapeutics Intends To Offer To Sell Common Shares And Warrants In Public Offering; No Terms Disclosed
BriaCell Therapeutics Intends To Offer To Sell Common Shares And Warrants In Public Offering; No Terms Disclosed
BriaCell Therapeutics打算公開發行普通股和Warrants; 沒有透露條款
All of the common shares and warrants are to be sold by the Company. The Company intends to use the net proceeds from the offering primarily for working capital requirements, general corporate purposes, and the advancement of business objectives.
所有普通股和認股權證將由公司出售。公司打算將本次發行的淨收益主要用於營運資金需求、一般公司用途和推進業務目標。
資訊熱榜
更新時間